AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q/C TECHNOLOGIES, INC. Director's Dealing 2023

Jun 10, 2023

35313_dirs_2023-06-09_d9918665-7880-4459-b4e5-565815f12323.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MyMD Pharmaceuticals, Inc. (MYMD)
CIK: 0001321834
Period of Report: 2023-06-07

Reporting Person: Silverman Joshua (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-07	Employee Stock Option (Right to Buy)	$1.66	A	200000	Acquired	2028-06-07	Common Stock (200000)	Direct

Footnotes

F1: The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date.